Search

Your search keyword '"Goya, Sho"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Goya, Sho" Remove constraint Author: "Goya, Sho"
189 results on '"Goya, Sho"'

Search Results

4. Supplementary Figure 1 from Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung

5. Supplementary Figure Legends 1 from Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung

6. Data from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

7. Supplementary Figure 1 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

8. Supplementary Table 4 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

9. Supplementary Table 2 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

10. Supplementary Methods, Figures 1-2 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

11. Supplementary Table 1 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

12. Supplementary Table 3 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

13. Supplementary Figure 2 from Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

14. Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer

15. The Effect of High-flow Nasal Cannula Oxygen for Dyspnea in Patients with Advanced Disease: Systematic Review

24. Hemophagocytic Lymphohistiocytosis That Developed Soon After the Initial Administration of Atezolizumab, Which Is an Anti-PD-L1 Antibody Drug, and Thereafter Deteriorated Rapidly: an Autopsy Case

27. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis

36. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo

38. Clinical Course of Lung Cancer Patients with Subcutaneously Implanted Central Venous Access Device Ports from the Time of Receiving Chemotherapy to the Endpoint of Cancer

39. Novel Therapeutic Strategies for Delirium in Patients With Cancer

40. 4-Hydroxy-2-nonenal induces endothelial cell injury via PKCdelta and biphasic JNK activation

41. Deletion of Tetraspanin CD9 Diminishes Lymphangiogenesis in Vivo and in Vitro

42. An Inhibitory Role for Sema4A in Antigen-Specific Allergic Asthma

43. Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis

45. Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung

46. Safe and Successful Treatment With Erlotinib After Gefitinib-Induced Hepatotoxicity: Difference in Metabolism As a Possible Mechanism

47. Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib

50. Apoptotic Cells Activate NKT Cells through T Cell Ig-Like Mucin-Like–1 Resulting in Airway Hyperreactivity

Catalog

Books, media, physical & digital resources